2001
DOI: 10.1016/s0163-7258(01)00157-7
|View full text |Cite
|
Sign up to set email alerts
|

Pulmonary vascular remodeling: a target for therapeutic intervention in pulmonary hypertension

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2
1

Citation Types

10
172
3
1

Year Published

2003
2003
2020
2020

Publication Types

Select...
9
1

Relationship

0
10

Authors

Journals

citations
Cited by 253 publications
(192 citation statements)
references
References 155 publications
10
172
3
1
Order By: Relevance
“…Pulmonary vascular remodeling is an important pathological part of pulmonary hypertension, leading to increased pulmonary vascular resistance and reduced vascular compliance. The increase in tenascin-C stimulates pulmonary vasculary remodeling 23) . Cowan et al showed in rats that pulmonary artery pressure and muscularization were reduced by myocyte apoptosis and loss of extracellular matrix, specifically elastin and tenascin-C 24) .…”
Section: Introductionmentioning
confidence: 99%
“…Pulmonary vascular remodeling is an important pathological part of pulmonary hypertension, leading to increased pulmonary vascular resistance and reduced vascular compliance. The increase in tenascin-C stimulates pulmonary vasculary remodeling 23) . Cowan et al showed in rats that pulmonary artery pressure and muscularization were reduced by myocyte apoptosis and loss of extracellular matrix, specifically elastin and tenascin-C 24) .…”
Section: Introductionmentioning
confidence: 99%
“…Bovine pulmonary artery endothelial cells (BPAECs) are one model system for studying functionally important aspects of cytoskeleton. These cells are derived from the pulmonary vascular endothelium, where they function as a semi-permeable barrier [13]. In several instances, alterations of barrier permeability are mediated by cytoskeletal rearrangements, and hence cytoskeletal organization in these cells has been studied in some detail [14].…”
Section: Introductionmentioning
confidence: 99%
“…Pulmonary artery endothelial cells (PAECs) exposed to cyclic strain induce vascular endothelial cell growth factor and platelet-derived growth factor, which stimulate pulmonary artery smooth muscle cell (PASMC) growth (5,6). PAECs also produce factors that inhibit PASMC growth, such as nitric oxide (7), prostacyclin (8), heparin-like compounds (9)(10)(11), and xanthine oxidase (12).…”
mentioning
confidence: 99%